Crossmark Global Holdings’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,280
Closed -$227K 1311
2026
Q1
$227K Buy
2,280
+5
+0.2% +$652 ﹤0.01% 1149
2025
Q4
$277K Buy
2,275
+88
+4% +$11K ﹤0.01% 1058
2025
Q3
$245K Sell
2,187
-282
-11% -$33K ﹤0.01% 1179
2025
Q2
$331K Buy
+2,469
New +$271K 0.01% 1055

Other funds holding TMDX

Crossmark Global Holdings's TMDX Position: Q2 2026 in Review

Crossmark Global Holdings sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 2,280 shares — an estimated $227K sold.

Crossmark Global Holdings first reported a position in TMDX in Q2 2025 and held it in 4 quarters. The position peaked at $331K in Q2 2025. 34 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Crossmark Global Holdings reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Crossmark Global Holdings sold 2,280 Transmedics shares in Q2 2026, an estimated $227K.
  • Crossmark Global Holdings first reported a position in Transmedics in Q2 2025 and held it in 4 quarters.
  • Crossmark Global Holdings's Transmedics position peaked at $331K in Q2 2025.
  • 34 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.